Peter Joyce

Company: Grey Wolf Therapeutics
Job title: Chief Executive Officer, Co-Founder
Seminars:
Targeting ERAP1 to Alter the Cancer Immunopeptidome 10:30 am
day: Day One
Company: Grey Wolf Therapeutics
Job title: Chief Executive Officer, Co-Founder
day: Day One